In tumour immunity, CD4+ T cells activate CD8+ T cells through various mechanisms and promote their differentiation into cytotoxic T lymphocytes (CTLs) to maintain and strengthen the antitumour response of CTLs. This evidence concerns the gene CD8A and neoplasm.